Sight Sciences, Inc. (SGHT)
Makes surgical devices that treat glaucoma and dry eye disease.
$5.32+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+62.7%
The outlook
Sight Sciences trades at $5.32, positioned about one-third of the way up from its 52-week low. Analyst coverage shows a notably bullish average price target roughly 58% above current levels, though the stock's mixed positioning against moving averages suggests near-term direction remains unclear. Overall sentiment is neutral.
What’s behind the score
Price trendMixed vs its moving averages
52-week range36% of the way from its 52-week low to high
Price targetAvg target +58% vs current price
Analyst price target
~12-month · 5 analysts$8.40average target+57.9% vs now
Now $5.32
Low $6.00High $12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$289.5M
52-wk high
$9.24
52-wk low
$3.11
50-day avg
$5.06
200-day avg
$5.50
Trailing P/E
—